Finerenone and Cardiac Remodeling in HFpEF

Summary

This prospective randomized study aims to evaluate the efficacy of Finerenone as add-on therapy to standard of care compared to standard of care alone in preventing heart failure worsening and preserving cardiac function assessed by left ventricular strain in patients with heart failure with preserved ejection fraction.

Timeline

Start

2026-09-20

Primary completion

2027-09-25

Completion

2028-03-25

Drugs

Indications